ArticleGynecologic oncology2022

Contemporary primary treatment of women with stage II-IV low-grade serous ovarian/peritoneal cancer (LGSOC): Determinants of relapse and disease-free survival.

David M Gershenson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.